Median aromatase (CYP19) gene expression in GCs was nine times higher in control GLCs than in GCs (P < 0.0001) and five times lower in PCOS GLCs than in PCO GCs (P < 0.0001). The gene discussed is CYP19A1; the disease is polycystic ovary syndrome.